跳到正文
openFDA 已分级药品召回执法报告·· 12 天前精选AI 评分69

FDA 执法报告 D-0167-2027 将费森尤斯 DELFLEX 腹膜透析液召回列为 II 类

FDA drug enforcement D-0167-2027: Fresenius Medical Care Renal Therapies Group, LLC — Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.

AI 导读

FDA 执法报告 D-0167-2027 将 Fresenius Medical Care Renal Therapies Group 的 DELFLEX 腹膜透析液召回列为 II 类,原因为无菌保证不足。

推荐理由

记录列出受影响批号、有效期、包装规格与美国全国分销范围,便于核对具体批次及无菌保证不足的说明。

正文 · AI 翻译

FDA 药品召回执行报告 — D-0167-2027

报告发布日期:2026-11-11。这是执行报告的日期,不是召回启动日期。

范围:一条已分类的药品召回记录;event_id 可能归组多个产品。没有召回编号的未分类记录不在本数据流范围内。本记录不是新闻稿,也不是新的执法认定。

openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于跟踪召回生命周期。以下其他日期保留其各自名称所表示的含义。

完整官方产品记录(包括 openFDA 统一标识符):

{

"address_1": "350 Merrimack St",

"address_2": "",

"center_classification_date": "20261103",

"city": "Lawrence",

"classification": "Class II",

"code_info": "批号:25JGPD045、批号 25JGPD046、批号 25JGPD060,有效期至 2027/1/31;25KGPD057,有效期至 2027/2/28。",

"country": "United States",

"distribution_pattern": "美国全国范围。",

"event_id": "100130",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {

"application_number": [

"NDA020171"

],

"brand_name": [

"DELFLEX"

],

"generic_name": [

"DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"

],

"is_original_packager": [

true

],

"manufacturer_name": [

"Fresenius Medical Care de Mexico, S.A. de C.V."

],

"package_ndc": [

"46163-209-92",

"46163-209-94",

"46163-209-95",

"46163-212-95",

"46163-212-92",

"46163-212-94",

"46163-206-92",

"46163-206-94",

"46163-206-95"

],

"product_ndc": [

"46163-206",

"46163-209",

"46163-212"

],

"product_type": [

"HUMAN PRESCRIPTION DRUG"

],

"route": [

"INTRAPERITONEAL"

],

"spl_id": [

"5f14959c-adcd-923c-e063-6294a90ab6de"

],

"spl_set_id": [

"a98facd6-9daa-4d37-8209-63a0599dbfaa"

],

"substance_name": [

"DEXTROSE MONOHYDRATE",

"SODIUM CHLORIDE",

"SODIUM LACTATE",

"CALCIUM CHLORIDE",

"MAGNESIUM CHLORIDE"

],

"unii": [

"TU7HW0W0QT",

"LX22YL083G",

"02F3473H9O",

"451W47IQ8X",

"M4I0D6VV5M"

]

},

"postal_code": "01843-1748",

"product_description": "DELFLEX 腹膜透析液,含 1.5% 葡萄糖,低镁/低钙,附带 stay safe 交换装置,2,000 mL - 单剂量袋,无菌且无热原,仅限处方,CAT.NO. 054-20221。Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843。NDC 46163-206-92",

"product_quantity": "4,232 箱(每箱 5 袋)",

"product_type": "Drugs",

"reason_for_recall": "无菌保证不足:已收到投诉,涉及受影响批次主袋印刷区域的小穿孔可能导致泄漏。",

"recall_initiation_date": "20261014",

"recall_number": "D-0167-2027",

"recalling_firm": "Fresenius Medical Care Renal Therapies Group, LLC",

"report_date": "20261111",

"state": "MA",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov